1555P Keynote-G08: An open-label, multicenter, dose escalation and expansion phase I/II study of GI-102 (CD80/IL2v3) in advanced solid tumors (part A and D of GII-102-P101)
S. T. Kim, Jes Chauviere Lee, B.C. Cho, Sarah J. Shin, June‐Yong Lee, Jia-Lin Lee, Weiguo Ma, Alex A. Adjei, Jian Campian, Yujie Zhao, S Mahesh, Byoung Yong Shim, S-A Im, Jae Wook Lee, V. Avutu, Sandra P. D’Angelo, Michael Chisamore, E. Angstadt, Nicole K. Yun, Myoung Ho Jang
IF 65.4 (2025) Annals of Oncology
키워드
Solid tumorPhase (matter)Maximum tolerated doseResponse Evaluation Criteria in Solid TumorsPhases of clinical research